Mechanisms to facilitate the development of autoimmune arthritis by over-expression of HTLV-1pX.
Mechanisms to facilitate the development of autoimmune arthritis by over-expression of HTLV-1pX.
批准号:
15590439
负责人:
ISHIHARA Katsuhiko
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We generated a double-mutant mouse by crossing two murine models of RA, a gp 130 mutant knock-in mouse (gp130^<F759/F759>) and an HTLV-1 pX transgenic mouse (pX-Tg), in a C57BL/6 background, which is resistant to arthritis. The mice spontaneously developed severe arthritis with a much earlier onset than the gp130^<F759/F759> mice and with a much higher incidence than did the pX-Tg mice. The symptoms of gp130^<F759/F759> mice, including lymphoadenopathy, splenomegaly, hyper-γ-globulinemia, autoantibody production, increases in memory/activated T cells and granulocytes in the peripheral lymphoid organs, and a decrease in the class II MHC^<bright> CD11c^+ population, were augmented in the double mutants. Immunohistochemical analyses revealed production of IL-6 and nuclear translocation of phospho-STAT3 in the macrophages and fibroblasts in the synovium of arthritic joints. CD4^+ T cells are closely located to the class II MHC molecules expressed by CD11b^+ cells in the synovium. Marked reductions in incidence, severity, and immunological abnormalities were seen in the triple mutant, IL-6^<-/->/gp130^<F759/F759>/pX-Tg, indicating that the arthritis in the double mutant is IL-6 dependent. Inhibitory effects on the maturation of dendritic cells by IL-6/STAT3 signal were demonstrated in vivo and in vitro. Experiments of bone marrow transfer revealed that both the gp130^<F759/F759> mutation and over-expression of pX gene in the non-hematopoietic cells but not in hematopoietic cells are required for the development of arthritis.
期刊论文(32)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1182/blood-2004-01-0247
发表时间:
2004-09-15
期刊:
BLOOD
影响因子:
20.3
作者:
[Morii, E, Oboki, K, Kitamura, Y]
通讯作者:
Kitamura, Y
DOI:
10.4049/jimmunol.173.7.4360
发表时间:
2004-10-01
期刊:
JOURNAL OF IMMUNOLOGY
影响因子:
4.4
作者:
[Esashi, E, Ito, H, Miyajima, A]
通讯作者:
Miyajima, A
The point mutation of Y759 of the IL-6 family receptor gp130 synergizes with HTLV-1 pX in promoting RA-like arthritis.
IL-6 家族受体 gp130 的 Y759 点突变与 HTLV-1 pX 协同促进 RA 样关节炎。
DOI:
--
发表时间:
2004
期刊:
Int.Immunol. 16
影响因子:
--
作者:
[Ishihara K, et al.]
通讯作者:
et al.
DOI:
10.4049/jimmunol.173.6.3844
发表时间:
2004-09-15
期刊:
JOURNAL OF IMMUNOLOGY
影响因子:
4.4
作者:
[Park, SJ, Nakagawa, T, Hirano, T]
通讯作者:
Hirano, T
Evidence of a novel IL-2/15Rbeta-targeted cytokine involved in homeostatic proliferation of memory CD8+ T cells.
一种新型 IL-2/15Rbeta 靶向细胞因子参与记忆 CD8 T 细胞稳态增殖的证据。
DOI:
--
发表时间:
2004
期刊:
J.Immunol. 173
影响因子:
--
作者:
[Kamimura D, et al.]
通讯作者:
et al.
共 8 条
Spatiotemporal pathophysiology of systemic immunological disorders and autoimmune arthritis caused by aberrant cytokine signaling
-
批准号:21590448
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2009
-
负责人:ISHIHARA Katsuhiko
-
依托单位:
Abnormality of synovial mesenchymal cells in autoimmune arthritis
-
批准号:19590390
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2007
-
负责人:ISHIHARA Katsuhiko
-
依托单位:
Analysis of the function of bone marrow stromal cell antigen, BST-1 (CD157) to support B cells
-
批准号:10670301
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.92万
-
财政年份:1998
-
负责人:ISHIHARA Katsuhiko
-
依托单位:
国内基金
海外基金
登录
查看更多内容
EGR1/gp130轴调节铁代谢在低氧微环境促宫颈癌细胞免疫逃逸中的作用及机制研究
-
批准号:JCZRLH202600339
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
复方清胰汤对肠道菌群、黏膜屏障功能以及对 IL-6/gp130 信
号通路的影响机制研究
-
批准号:2024JJ9528
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:易晓雷
-
依托单位:
IL11-IL11Rα/GP130通过ERK信号通路促进克罗恩病爬行脂肪纤维化形成的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:熊珊珊
-
依托单位:
GP130信号阻滞CAR-T细胞耗竭的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:蒋治武
-
依托单位:
GP130通过JAK/STAT3和AP-1通路阻滞CAR-T细胞耗竭的机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:58万元
-
批准年份:2021
-
负责人:蒋治武
-
依托单位:
IL-6/GP130信号通路介导反Warburg效应调控心肌细胞和心脏成纤维细胞间交互作用及其在糖尿病心肌病代谢重构中的机制研究
-
批准号:82070396
-
项目类别:面上项目
-
资助金额:54.0万元
-
批准年份:2020
-
负责人:吕家高
-
依托单位:
OSMR/gp130信号通路在心肌细胞增殖与心肌损伤修复中的作用与机制研究
-
批准号:81970243
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:聂宇
-
依托单位:
胃癌细胞gp130信号促进肿瘤相关巨噬细胞分泌galectin-9介导胃癌免疫逃逸的机制研究
-
批准号:81871926
-
项目类别:面上项目
-
资助金额:54.0万元
-
批准年份:2018
-
负责人:秦净
-
依托单位:
IL-6上调3ˊ-磷酸腺苷5ˊ-磷酸硫酸合成酶2(PAPSS2)表达促进强直性脊柱炎韧带骨化的作用机制
-
批准号:81701620
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:郑凯迪
-
依托单位:
雌激素受体结合gp130胞内结构域抑制IL-6/gp130炎症信号通路的抗动脉粥样硬化分子机制研究
-
批准号:81772265
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2017
-
负责人:李艳
-
依托单位: